Covered recipient · General Payments record
MATTHEW ALLEN ERBY
Allopathic & Osteopathic Physicians Physical Medicine & Rehabilitation
General Payments · PY2021–2024
$587.63
- Reported across 20 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $267.22 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $99.27 | 4 |
| Ipsen Biopharmaceuticals, Inc | $75.51 | 3 |
| Merz Pharmaceuticals, LLC | $44.31 | 1 |
| SPR Therapeutics, Inc | $24.75 | 1 |
| SCILEX PHARMACEUTICALS INC. | $23.38 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.00 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103695712 | CMS |
| ABBVIE INC. | $16.50 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103695714 | CMS |
| ABBVIE INC. | $30.06 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103695716 | CMS |
| ABBVIE INC. | $28.71 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103695718 | CMS |
| Ipsen Biopharmaceuticals, Inc | $29.00 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091952819 | CMS |
| Ipsen Biopharmaceuticals, Inc | $23.31 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091952817 | CMS |
| Ipsen Biopharmaceuticals, Inc | $23.20 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091952821 | CMS |
| Merz Pharmaceuticals, LLC | $44.31 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137952240 | CMS |
| SCILEX PHARMACEUTICALS INC. | $23.38 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136286220 | CMS |
| SPR Therapeutics, Inc | $24.75 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104936365 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.